Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$34.64
-0.1%
$33.87
$26.56
$58.00
$1.00B0.73476,482 shs445,316 shs
Paragon 28, Inc. stock logo
FNA
Paragon 28
$13.11
+0.1%
$13.08
$4.65
$13.13
$1.10B1.471.12 million shs19.38 million shs
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$17.46
-2.1%
$16.74
$9.70
$25.00
$1.17B1.6190,206 shs154,702 shs
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
$26.40
-6.3%
$30.56
$5.17
$39.50
$224.16M1.2532,059 shs58,657 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
0.00%-5.41%+11.60%-19.20%-33.02%
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.00%0.00%0.00%+1.00%+68.23%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
0.00%+3.37%+1.69%-4.64%+38.35%
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
0.00%-7.53%-9.37%+2,639,999,900.00%+2,639,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.9937 of 5 stars
3.43.00.00.03.52.50.6
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/AN/AN/AN/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
0.9534 of 5 stars
0.00.00.04.22.43.30.0
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.83
Moderate Buy$55.3359.74% Upside
Paragon 28, Inc. stock logo
FNA
Paragon 28
2.20
Hold$12.75-2.71% Downside
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
0.00
N/AN/AN/A
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SNWV, FNA, PLSE, and ESTA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/16/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Buy$62.00
5/14/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$48.00
4/14/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold
3/6/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$52.00 ➝ $52.00
(Data available from 6/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$170.24M5.88N/AN/A$0.71 per share48.79
Paragon 28, Inc. stock logo
FNA
Paragon 28
$256.18M4.29N/AN/A$2.05 per share6.39
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$700K1,678.01N/AN/A$0.81 per share21.56
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
$36.19M6.24N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$78.50M-$3.10N/AN/AN/A-46.13%-184.55%-24.81%8/5/2025 (Estimated)
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$57.53M-$0.63N/AN/AN/A-25.31%-37.90%-18.22%N/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
-$42.21MN/A0.00N/AN/A-96.89%-74.83%8/11/2025 (Estimated)
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/A-$4.56N/AN/AN/AN/AN/AN/A

Latest SNWV, FNA, PLSE, and ESTA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/A-$0.66N/A-$0.66N/A$9.34 million
5/8/2025Q1 2025
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/A-$0.25N/A-$0.25N/AN/A
5/7/2025Q1 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million
3/6/2025Q4 2024
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$0.12-$0.13-$0.01-$0.13$70.81 million$71.75 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
5.94
3.62
2.29
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.79
3.50
1.60
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/A
11.93
11.93
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
Paragon 28, Inc. stock logo
FNA
Paragon 28
63.57%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
76.95%
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
42.53%

Insider Ownership

CompanyInsider Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11.09%
Paragon 28, Inc. stock logo
FNA
Paragon 28
15.32%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
71.50%
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
36.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
96028.92 million24.80 millionOptionable
Paragon 28, Inc. stock logo
FNA
Paragon 28
343,00083.94 million70.89 millionOptionable
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
14067.27 million17.53 millionOptionable
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
408.56 millionN/AN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$34.64 -0.04 (-0.12%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$34.83 +0.19 (+0.55%)
As of 05/30/2025 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Paragon 28 stock logo

Paragon 28 NYSE:FNA

$13.10 +0.02 (+0.11%)
Closing price 04/17/2025
Extended Trading
$13.10 0.00 (0.00%)
As of 04/17/2025 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Pulse Biosciences stock logo

Pulse Biosciences NASDAQ:PLSE

$17.46 -0.38 (-2.13%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$17.27 -0.19 (-1.09%)
As of 05/30/2025 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

SANUWAVE Health stock logo

SANUWAVE Health NASDAQ:SNWV

$26.40 -1.78 (-6.32%)
As of 05/30/2025 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.